Phase IIb clinical trial for ELGN-EYE for the treatment of pre-term infants retinopathy of prematurity
Latest Information Update: 08 Mar 2022
At a glance
- Drugs ELGN-EYE (Primary)
- Indications Retinopathy of prematurity
- Focus Therapeutic Use
- Sponsors Elgan Pharma
Most Recent Events
- 08 Mar 2022 New trial record